View Older Stories

Feb 25, 2026 07:27AM Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

Feb 10, 2026 07:29AM Cardiol publishes phase II study results in ESC Heart Failure journal

Feb 10, 2026 07:27AM Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Jan 23, 2026 09:16AM Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Jan 16, 2026 08:48AM Cardiol Therapeutics raises $13.5 million in bought deal financing

Jan 16, 2026 08:46AM Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Jan 16, 2026 08:43AM Cardiol Therapeutics raises $13.5 million in bought deal financing

Jan 16, 2026 08:42AM Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Jan 13, 2026 07:29AM Cardiol Therapeutics reaches 50% enrollment in phase III pericarditis trial

Jan 13, 2026 07:27AM Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Dec 2, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Cardiol Therapeutics (CRDL)

Dec 1, 2025 07:29AM Cardiol reports heart structure improvements in myocarditis trial

Dec 1, 2025 07:27AM New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

Nov 13, 2025 07:48AM Cardiol Therapeutics receives U.S. patent allowance for heart drugs through 2040

Nov 13, 2025 07:45AM Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

Nov 5, 2025 07:45AM Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

Oct 21, 2025 07:27AM Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027

Oct 17, 2025 04:36PM Cardiol Therapeutics raises $11 million, extends cash runway to Q3 2027

Oct 17, 2025 04:34PM Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

Sep 17, 2025 03:33PM Brookline Capital Markets Starts Cardiol Therapeutics (CRDL) at Buy, PT $6

Aug 11, 2025 07:27AM Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference

Aug 6, 2025 07:27AM Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis

Jul 23, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Cardiol Therapeutics (CRDL)

Jul 22, 2025 07:30AM Cardiol locks database for phase II myocarditis trial

Jul 22, 2025 07:27AM Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis

Jun 2, 2025 06:36AM H.C. Wainwright Starts Cardiol Therapeutics (CRDL) at Buy

May 29, 2025 07:27AM Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

May 27, 2025 07:27AM Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT

Apr 29, 2025 07:29AM Cardiol Therapeutics (CRDL) Nominates Timothy Garnett to Its Board

Apr 29, 2025 07:27AM Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Apr 16, 2025 07:29AM Cardiol Therapeutics (CRDL) Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Apr 16, 2025 07:27AM Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Apr 8, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Cardiol Therapeutics (CRDL)

Apr 1, 2025 07:29AM Cardiol Therapeutics (CRDL) Issues Year-end Update on Operations

Apr 1, 2025 07:27AM Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Mar 3, 2025 07:27AM Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Feb 20, 2025 07:29AM Cardiol Therapeutics (CRDL) Announces Publication of Research in the Journal of the American College of Cardiology

Feb 20, 2025 07:27AM Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Dr

Feb 4, 2025 07:27AM Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 28, 2025 06:45AM Rodman & Renshaw Starts Cardiol Therapeutics (CRDL) at Buy

Nov 18, 2024 11:37AM Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Oct 24, 2024 07:44AM H.C. Wainwright Reiterates Buy Rating on Cardiol Therapeutics (CRDL)

Oct 22, 2024 06:32AM Cardiol Therapeutics (CRDL) to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

Oct 22, 2024 06:30AM Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

Oct 20, 2024 10:00AM 4 biotech stocks to own to benefit from key Q4 catalysts

Oct 11, 2024 08:39AM Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Oct 10, 2024 09:09AM Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Oct 9, 2024 08:01AM Cardiol Therapeutics (CRDL) Announces Pricing of Public Offering of Common Shares

Oct 9, 2024 07:58AM Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

Oct 8, 2024 04:03PM Cardiol Therapeutics (CRDL) Files Preliminary Prospectus Supplement for Proposed Share Offering

View Older Stories